Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2013
Progression of patellar tendinitis following treatment with platelet-rich plasma: case reports.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bowman Karl F, Muller Bart, Middleton Kellie, Fink Christian, Harner Christopher D, Fu Freddie H
Аннотация
PURPOSE: The use of platelet-rich plasma (PRP) is becoming more attractive given its favourable side effect profile and autologous nature, leading to rapid clinical adoption in the absence of high-level evidence. We are presenting three patients who developed a progression of patellar tendinitis following treatment, which to our knowledge is the first report of worsening of patellar tendinitis following PRP therapy.
METHODS: The records of three patients with symptom exacerbation of patellar tendinitis following treatment with PRP were reviewed. IRB exemption was obtained. Clinical and operative records, radiographs, and MR imaging were reviewed for all patients.
RESULTS: Three patients reported to our clinic for a second opinion with symptoms of anterior knee pain consistent with patellar tendinitis. Each patient had previously been treated with PRP therapy due to prolonged symptoms. Clinical and radiological findings following treatment included patellar tendon thickening, worsening pain, discontinuation of athletic participation in all three patients, and osteolysis of the distal pole of the patella in one patient identified during surgical intervention.
CONCLUSIONS: Growing interest in the use of autologous products for the management of chronic tendinopathies has led to widespread clinical implementation with minimal scientific support. It is tempting to apply a new treatment for management of a difficult clinical entity, especially when the risk/benefit ratio appears favourable. However, caution must be exercised as unexpected results may be encountered.
LEVEL OF EVIDENCE: Case reports, level V.
METHODS: The records of three patients with symptom exacerbation of patellar tendinitis following treatment with PRP were reviewed. IRB exemption was obtained. Clinical and operative records, radiographs, and MR imaging were reviewed for all patients.
RESULTS: Three patients reported to our clinic for a second opinion with symptoms of anterior knee pain consistent with patellar tendinitis. Each patient had previously been treated with PRP therapy due to prolonged symptoms. Clinical and radiological findings following treatment included patellar tendon thickening, worsening pain, discontinuation of athletic participation in all three patients, and osteolysis of the distal pole of the patella in one patient identified during surgical intervention.
CONCLUSIONS: Growing interest in the use of autologous products for the management of chronic tendinopathies has led to widespread clinical implementation with minimal scientific support. It is tempting to apply a new treatment for management of a difficult clinical entity, especially when the risk/benefit ratio appears favourable. However, caution must be exercised as unexpected results may be encountered.
LEVEL OF EVIDENCE: Case reports, level V.